BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEMENTIA RESEARCHER - ECPv6.14.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DEMENTIA RESEARCHER
X-ORIGINAL-URL:https://www.dementiaresearcher.nihr.ac.uk
X-WR-CALDESC:Events for DEMENTIA RESEARCHER
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20261007T120000
DTEND;TZID=Europe/London:20261007T124500
DTSTAMP:20260814T123911
CREATED:20260810T180216Z
LAST-MODIFIED:20260810T180216Z
UID:10002350-1791374400-1791377100@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Research Showcase - What Should MCI Clinical Trials Measure?
DESCRIPTION:When we test new treatments or interventions for mild cognitive impairment\, what outcomes should actually matter. And are researchers measuring the things that people with MCI and their families consider most important? \nThis livestream is part of the Dementia Researcher weekly Showcase series. Each week we host a 45 minute online session bringing researchers together to share their work\, methods\, and ideas. \nIn this session\, Victoria Gabb will present work developing a core outcome set for research involving people with mild cognitive impairment (MCI). The project brought together the priorities of people with MCI\, family members\, researchers\, and healthcare professionals to identify which outcomes should be consistently measured in future clinical trials. \nVictoria will discuss how the core outcome set was developed\, where different groups agreed or disagreed about what matters\, and why greater consistency in outcome measurement could make it easier to compare studies and build stronger evidence. \nVictoria is a Senior Research Associate at the University of Bristol. Her research focuses on sleep and memory in MCI and early dementia due to Alzheimer’s disease\, Lewy body disease\, and Parkinson’s disease. She is also an academic co-lead for patient and public involvement and engagement within the mental health theme at the NIHR Bristol Biomedical Research Centre. \nAttendees can expect a practical and research focused session with time for questions and discussion. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/research-showcase-what-should-mci-clinical-trials-measure/
LOCATION:Dementia Researcher Communities App
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/08/What-Should-MCI-Clinical-Trials-Measure-web.png
END:VEVENT
END:VCALENDAR